These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27886452)

  • 21. Coronary perforation after bioresorbable vascular scaffold implantation.
    Gomez-Lara J; Teruel L; Romaguera R; Roura G; Ferreiro JL; Sanchez-Elvira G; Gomez-Hospital JA; Cequier A
    EuroIntervention; 2015 Apr; 10(12):e1-2. PubMed ID: 25912645
    [No Abstract]   [Full Text] [Related]  

  • 22. Neointimal proliferation is associated with clinical restenosis 2 years after fully bioresorbable vascular scaffold implantation.
    Indolfi C; Mongiardo A; Spaccarotella C; Caiazzo G; Torella D; De Rosa S
    Circ Cardiovasc Imaging; 2014 Jul; 7(4):755-7. PubMed ID: 25027457
    [No Abstract]   [Full Text] [Related]  

  • 23. Bioresorbable vascular scaffolds: implication of very late scaffold thrombosis.
    Mori H; Virmani R; Finn AV
    Coron Artery Dis; 2017 Nov; 28(7):533-538. PubMed ID: 28692483
    [No Abstract]   [Full Text] [Related]  

  • 24. First ad hoc bioresorbable vascular scaffold bench test: a glimpse into percutaneous bifurcation interventions.
    Sgueglia GA; D'Errico F; Gioffrè G; De Santis A; Gaspardone A
    Int J Cardiol; 2014 Apr; 172(3):604-6. PubMed ID: 24491860
    [No Abstract]   [Full Text] [Related]  

  • 25. Salvage of side branch by provisional "TAP technique" using Absorb™ bioresorbable vascular scaffolds for bifurcation lesions: first case reports with technical considerations.
    Seth A; Sengottuvelu G; Ravisekar V
    Catheter Cardiovasc Interv; 2014 Jul; 84(1):55-61. PubMed ID: 24677764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and receding of a coronary artery aneurysm after implantation of a fully bioresorbable scaffold.
    Nakatani S; Ishibashi Y; Suwannasom P; Grundeken MJ; Høj Christiansen E; Onuma Y; Serruys PW;
    Circulation; 2015 Feb; 131(8):764-7. PubMed ID: 25712060
    [No Abstract]   [Full Text] [Related]  

  • 27. Resistant in-stent restenosis in the drug eluting stent era.
    Theodoropoulos K; Mennuni MG; Dangas GD; Meelu OA; Bansilal S; Baber U; Sartori S; Kovacic JC; Moreno PR; Sharma SK; Mehran R; Kini AS
    Catheter Cardiovasc Interv; 2016 Nov; 88(5):777-785. PubMed ID: 27184223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Everolimus-eluting bioresorbable vascular scaffolds versus second generation drug-eluting stents for percutaneous treatment of chronic total coronary occlusions: Technical and procedural outcomes from the GHOST-CTO registry.
    La Manna A; Chisari A; Giacchi G; Capodanno D; Longo G; Di Silvestro M; Capranzano P; Tamburino C
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):E155-E163. PubMed ID: 26756959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.
    Serruys PW; Onuma Y; Ormiston JA; de Bruyne B; Regar E; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Miquel-Hebert K; Rapoza R; García-García HM
    Circulation; 2010 Nov; 122(22):2301-12. PubMed ID: 21098436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term safety of an everolimus-eluting bioresorbable vascular scaffold and the cobalt-chromium XIENCE V stent in a porcine coronary artery model.
    Otsuka F; Pacheco E; Perkins LE; Lane JP; Wang Q; Kamberi M; Frie M; Wang J; Sakakura K; Yahagi K; Ladich E; Rapoza RJ; Kolodgie FD; Virmani R
    Circ Cardiovasc Interv; 2014 Jun; 7(3):330-42. PubMed ID: 24895447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late Self-Apposition With One-Year Persisting Uncoverage of Malapposed Bioresorbable Polymeric Struts.
    Francaviglia B; Capranzano P; Capodanno D; Barbanti M; Tamburino CI; Buccheri S; Tamburino C
    Can J Cardiol; 2017 Jul; 33(7):951.e5-951.e6. PubMed ID: 28579161
    [No Abstract]   [Full Text] [Related]  

  • 32. The usefulness of a perfusion balloon in a case of late stent thrombosis that caused simultaneous double vessel occlusion.
    Nakabayashi K; Okada H; Asano R; Nakazawa N; Nomura H; Oka T
    Cardiovasc Interv Ther; 2016 Jul; 31(3):226-30. PubMed ID: 25971225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: 5-Year Follow-Up.
    Serruys PW; Ormiston J; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Chevalier B; Smits P; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Wasungu L; Ediebah D; Veldhof S; Onuma Y
    J Am Coll Cardiol; 2016 Feb; 67(7):766-76. PubMed ID: 26892411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Provisional main branch stenting with drug-eluting stents after drug-eluting balloon treatment of the side branch: a simple and durable technique for treating bifurcation lesions.
    McCutcheon K; Garda R; Mkhwanazi L; Vachiat A; Ramjee R; Moosa J; Tsabedze N; Karolia S; Manga P
    Int J Cardiol; 2015 Mar; 182():294-6. PubMed ID: 25585366
    [No Abstract]   [Full Text] [Related]  

  • 35. Complex bifurcation lesions: Randomized comparison of a fully bioresorbable modified t stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds, an OCT study: Rationale and design of the COBRA II trial.
    Bennett J; Adriaenssens T; Desmet W; Dubois C
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):843-853. PubMed ID: 27184586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical "vacuum" inside of neoatherosclerosis long term after DES implantation: insights from optical coherence tomography.
    Granata F; Attizzani GF; Tartaglione D; Cappelli Bigazzi M; Bianchi R; Varricchio A; Russo MG; Calabrò P
    Int J Cardiol; 2015 Nov; 199():221-2. PubMed ID: 26209822
    [No Abstract]   [Full Text] [Related]  

  • 37. Computed tomography angiography for guiding and follow-up of magnesium-bioresorbable scaffold implantation.
    Opolski MP; Kepka C; Wojakowski W; Witkowski A
    Clin Res Cardiol; 2019 Mar; 108(3):344-346. PubMed ID: 30182164
    [No Abstract]   [Full Text] [Related]  

  • 38. Pitfalls of bioresorbable vascular scaffold thrombosis--be sure to cover it all.
    Abu Sharar H; Katus HA; Bekeredjian R
    Int J Cardiol; 2014 Dec; 177(3):1067-8. PubMed ID: 25465842
    [No Abstract]   [Full Text] [Related]  

  • 39. Long-term intravascular follow-up of coronary bifurcation treatment with Absorb bioresorbable vascular scaffold.
    Vanhaverbeke M; McCutcheon K; Dubois C; Bennett J
    Acta Cardiol; 2018 Aug; 73(4):413-414. PubMed ID: 29277145
    [No Abstract]   [Full Text] [Related]  

  • 40. [Complex coronary intervention with overlapping of bioresorbable scaffolds. Case report and new insights review in the use of bioresorbable vascular scaffolds guided by optical coherence tomography].
    Macías E; Amador E
    Arch Cardiol Mex; 2016; 86(2):170-4. PubMed ID: 26907194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.